Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 12, 2003 - Issue 4
Submit an article Journal homepage
29
Views
12
CrossRef citations to date
0
Altmetric
Review

Novel therapies for renal cell carcinoma – an update

Mayer Fishman H. Lee Moffitt Cancer Center & Research Institute, University of South Florida, MCC 4035, 12902 Magnolia Drive, Tampa, FL 33612, USA
&
Scott Antonia H. Lee Moffitt Cancer Center & Research Institute, University of South Florida, MCC 4035, 12902 Magnolia Drive, Tampa, FL 33612, USA
Pages 593-609 | Published online: 02 Mar 2005

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Philip E Shaheen & Ronald M Bukowski. (2005) Emerging drugs for renal cell carcinoma. Expert Opinion on Emerging Drugs 10:4, pages 773-795.
Read now

Articles from other publishers (11)

Mayer N. Fishman. 2007. Urological Cancers in Clinical Practice. Urological Cancers in Clinical Practice 161 186 .
Xiao-Ping He. (2006) Effects of recombinant human canstatin protein in the treatment of pancreatic cancer. World Journal of Gastroenterology 12:41, pages 6652.
Crossref
Beverly J. Drucker. (2005) Renal cell carcinoma: Current status and future prospects. Cancer Treatment Reviews 31:7, pages 536-545.
Crossref
Nicole Oehlrich, Gerard Devitt, Michael Linnebacher, Yvette Schwitalle, Sonja Groβkinski, Stefan Stevanovic & Margot Zöller. (2005) Generation of RAGE-1 and MAGE-9 peptide-specific cytotoxic T-Lymphocyte lines for transfer in patients with renal cell carcinoma. International Journal of Cancer 117:2, pages 256-264.
Crossref
Michael Staehler, Karl Rohrmann, Alexander Bachmann, Dirk Zaak, Christian G. Stief & Michael Siebels. (2005) Therapeutic approaches in metastatic renal cell carcinoma. BJU International 95:8, pages 1153-1161.
Crossref
Tim J. Dudderidge, Kai Stoeber, Marco Loddo, Geraldine Atkinson, Thomas Fanshawe, David F. Griffiths & Gareth H. Williams. (2005) Mcm2, Geminin, and KI67 Define Proliferative State and are Prognostic Markers in Renal Cell Carcinoma. Clinical Cancer Research 11:7, pages 2510-2517.
Crossref
Mayer N. Fishman. 2005. Urological Cancers. Urological Cancers 204 217 .
Susana Pereira, Pedro Alexandrino Fernandes & Maria João Ramos. (2004) Mechanism for ribonucleotide reductase inactivation by the anticancer drug gemcitabine. Journal of Computational Chemistry 25:10, pages 1286-1294.
Crossref
Cornelis F.M. Sier, Kyra A. Gelderman, Frans A. Prins & Arko Gorter. (2004) Beta-glucan enhanced killing of renal cell carcinoma micrometastases by monoclonal antibody G250 directed complement activation. International Journal of Cancer 109:6, pages 900-908.
Crossref
DEREK ATKINS, SOLDANO FERRONE, GERD E. SCHMAHL, STEFAN STÖRKEL & BARBARA SELIGER. (2004) Down-Regulation of HLA Class I Antigen Processing Molecules: An Immune Escape Mechanism of Renal Cell Carcinoma?. The Journal of Urology 171:2, pages 885-889.
Crossref
Daniel J Mollura, Joshua M Hare & Hamid Rabb. (2003) Stem-cell therapy for renal diseases. American Journal of Kidney Diseases 42:5, pages 891-905.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.